Fund detail
Viking Global Investors (Halvorsen)
hedge-fund, active
Quarters
52
2024-09-30
$27.44B
Positions
83
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
Price is the latest implied close from the selected quarter's 13F (value ÷ shares). Est. Cost is a running average that assumes each quarter's trades cleared near the midpoint of consecutive 13F closes (or yfinance VWAP when available). Most accurate for slow accumulators, least accurate for activists who build positions in a few days.
| # | Issuer | Value ↓ | Weight | Shares | Share Δ | Share Δ % | Prev Weight | First Held | Price | Est. Cost | Unrealized % | Status |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | BRIDGEBIO PHARMA INC BBIO | $639.6M | 2.33% | 25,120,991 | +0 | +0.00% | 2.45% | 2019-06-30 | $25 | ~$27 | -5.60% | |
| 2 | ADAPTIVE BIOTECHNOLOGIES COR ADPT | $153.6M | 0.56% | 29,993,708 | +0 | +0.00% | 0.42% | 2019-06-30 | $5 | ~$48 | -89.40% | |
| 3 | NEWAMSTERDAM PHARMA COMPANY | $133.2M | 0.49% | 8,024,565 | +0 | +0.00% | 0.59% | 2022-12-31 | $17 | ~$11 | +47.48% | |
| 4 | STANDARD BIOTOOLS INC LAB | $113.2M | 0.41% | 58,651,170 | +0 | +0.00% | 0.40% | 2024-03-31 | $2 | ~$3 | -28.78% | |
| 5 | PHARVARIS N V | $67.7M | 0.25% | 3,653,310 | +0 | +0.00% | 0.26% | 2021-03-31 | $19 | ~$24 | -21.60% | |
| 6 | IMMUNOVANT INC IMVT | $66.2M | 0.24% | 2,320,902 | +0 | +0.00% | 0.24% | 2024-03-31 | $29 | ~$32 | -9.95% | |
| 7 | ORIC PHARMACEUTICALS INC ORIC | $41.0M | 0.15% | 4,000,000 | +0 | +0.00% | 0.11% | 2024-03-31 | $10 | ~$14 | -25.45% | |
| 8 | EDGEWISE THERAPEUTICS INC EWTX | $39.5M | 0.14% | 1,481,146 | +0 | +0.00% | 0.10% | 2021-03-31 | $27 | ~$19 | +41.20% | |
| 9 | DAY ONE BIOPHARMACEUTICALS I DAWNGBX | $35.6M | 0.13% | 2,558,563 | +0 | +0.00% | 0.14% | 2021-06-30 | $14 | ~$17 | -17.00% | |
| 10 | INHIBRX BIOSCIENCES INC INBX | $28.0M | 0.10% | 1,787,705 | +0 | +0.00% | 0.10% | 2024-06-30 | $16 | ~$14 | +10.52% | |
| 11 | TREVI THERAPEUTICS INC TRVI | $14.7M | 0.05% | 4,400,000 | +0 | +0.00% | 0.05% | 2022-09-30 | $3 | ~$2 | +116.88% | |
| 12 | PEPGEN INC PEPG | $12.7M | 0.05% | 1,482,434 | +0 | +0.00% | 0.09% | 2022-06-30 | $9 | ~$10 | -13.90% | |
| 13 | RALLYBIO CORP | $4.9M | 0.02% | 4,194,777 | +0 | +0.00% | 0.02% | 2021-09-30 | $1 | ~$18 | -93.34% |